[Modern Healthcare] Excessive drug costs could invite price caps: AHIP’s Ignagni
By Paul Demko May 21, 2014 The steep cost of Sovaldi—Gilead… Read More
By Paul Demko May 21, 2014 The steep cost of Sovaldi—Gilead… Read More
By Jeff Overly May 21, 2014 Executives representing drugmakers,… Read More
By Joe and Teresa Graedon May 20, 2014 Cancer has become a cash cow for… Read More
By Tony Pugh May 20, 2014 The risk pools in these 24 states need these healthy… Read More
By George Lauer May 19, 2014 An effective, high-priced drug has… Read More
By Atia Musazay May 14, 2014 A breakthrough drug now on the market… Read More
By Robert Langreth May 7, 2014 The backlash over surging drug… Read More
By Andy Miller May 6, 2014 Probably the biggest ethical dilemma now… Read More
By Bruce Jaspen April 28, 2014 Medicaid health insurance programs for… Read More
By Jason Millman April 28, 2014 The new hepatitis C drug Sovaldi is… Read More
BY JAMES SUROWIECKI April 28 Issue Few people have done better in the… Read More
JUDY WOODRUFF April 23, 2014 Watch Story Here JUDY WOODRUFF: Now: Who… Read More